Validation and clinical application of a targeted next-generation sequencing gene panel for solid and hematologic malignancies

BACKGROUND: Next-generation sequencing (NGS) is a high-throughput technology that has become widely integrated in molecular diagnostics laboratories. Among the large diversity of NGS-based panels, the Trusight Tumor 26 (TsT26) enables the detection of low-frequency variants across 26 genes using the...

Descripción completa

Detalles Bibliográficos
Autores principales: Prieto-Potin, Iván, Carvajal, Nerea, Plaza-Sánchez, Jenifer, Manso, Rebeca, Aúz-Alexandre, Carmen Laura, Chamizo, Cristina, Zazo, Sandra, López-Sánchez, Almudena, Rodríguez-Pinilla, Socorro María, Camacho, Laura, Longarón, Raquel, Bellosillo, Beatriz, Somoza, Rosa, Hernández-Losa, Javier, Fernández-Soria, Víctor Manuel, Ramos-Ruiz, Ricardo, Cristóbal, Ion, García-Foncillas, Jesús, Rojo, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546223/
https://www.ncbi.nlm.nih.gov/pubmed/33083132
http://dx.doi.org/10.7717/peerj.10069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546223/
https://www.ncbi.nlm.nih.gov/pubmed/33083132
http://dx.doi.org/10.7717/peerj.10069

Ejemplares similares